ArticleOncoimmunology2015

The combination of a novel immunomodulator with a regulatory T cell suppressing antibody (DTA-1) regress advanced stage B16F10 solid tumor by repolarizing tumor associated macrophages

Sayantan Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.